The development of genomic technology for smart diagnosis and therapies for various diseases has lately been the most demanding area for computer-aided diagnostic and treatment research. Exponential breakthroughs in artificial intelligence and machine intelligence technologies could pave the way for identifying challenges afflicting the healthcare industry. Genomics is paving the way for predicting future illnesses, including cancer, Alzheimer’s disease, and diabetes. Machine learning advancements have expedited the pace of biomedical informatics research and inspired new branches of computational biology. Furthermore, knowing gene relationships has resulted in developing more accurate models that can effectively detect patterns in vast volumes of data, making classification models important in various domains. Recurrent Neural Network models have a memory that allows them to quickly remember knowledge from previous cycles and process genetic data. The present work focuses on type 2 diabetes prediction using gene sequences derived from genomic DNA fragments through automated feature selection and feature extraction procedures for matching gene patterns with training data. The suggested model was tested using tabular data to predict type 2 diabetes based on several parameters. The performance of neural networks incorporating Recurrent Neural Network (RNN) components, Long Short-Term Memory (LSTM), and Gated Recurrent Units (GRU) was tested in this research. The model’s efficiency is assessed using the evaluation metrics such as Sensitivity, Specificity, Accuracy, F1-Score, and Mathews Correlation Coefficient (MCC). The suggested technique predicted future illnesses with fair Accuracy. Furthermore, our research showed that the suggested model could be used in real-world scenarios and that input risk variables from an end-user Android application could be kept and evaluated on a secure remote server.

Over the past few years, a tremendous change has occurred in computer-aided diagnosis (CAD) technology. The evolution of numerous medical imaging techniques has enhanced the accuracy of the preliminary analysis of several diseases. Magnetic resonance imaging (MRI) is a prevalent technology extensively used in evaluating the progress of the spread of malignant tissues or abnormalities in the human body. This article aims to automate a computationally efficient mechanism that can accurately identify the tumor from MRI images and can analyze the impact of the tumor. The proposed model is robust enough to classify the tumors with minimal training data. The generative variational autoencoder models are efficient in reconstructing the images identical to the original images, which are used in adequately training the model. The proposed self-learning algorithm can learn from the insights from the autogenerated images and the original images. Incorporating long short-term memory (LSTM) is faster processing of the high dimensional imaging data, making the radiologist’s task and the practitioners more comfortable assessing the tumor’s progress. Self-learning models need comparatively less data for the training, and the models are more resource efficient than the various state-of-art models. The efficiency of the proposed model has been assessed using various benchmark metrics, and the obtained results have exhibited an accuracy of 89.7%. The analysis of the progress of tumor growth is presented in the current study. The obtained accuracy is not pleasing in the healthcare domain, yet the model is reasonably fair in dealing with a smaller size dataset by making use of an image generation mechanism. The study would outline the role of an autoencoder in self-learning models. Future technologies may include sturdy feature engineering models and optimized activation functions that would yield a better result.